Powered By Daylife
Other company news pages:

Abbott Laboratories News

Cargo's Crossroads

As a route for a majority of goods from Los Angeles and Long Beach ports, the Inland area benefits from jobs -- but at a price By DUG BEGLEY, JACK KATZANEK and DAVID DANELSKI The Press-Enterprise

Zimmer Shows Some Spine

Zimmer Holdings is stiffening up its spinal division with an acquisition from Abbott Laboratories. The maker of hip replacement materials is acquiring Abbott Laboratories' spinal division for $360.0 million in cash. Zimmer Spine, a subsidiary of Zimmer

Arthritis Drugs Raise Risk of Fatal Infections

The Food and Drug Administration warned yesterday that a handful of medications commonly prescribed to treat rheumatoid arthritis and other serious illnesses can raise the risk of fatal fungal infections. The drugs are called Enbrel, Remicade, Humira

FDA urges more caution over TNF blocker infections

WASHINGTON (Reuters) - U.S. health regulators ordered stronger warnings for prescription drugs to treat rheumatoid arthritis, Crohn's disease and other conditions on Thursday after dozens of patients contracted severe fungal infections and died.

Zimmer to buy Abbott's spine unit

Zimmer Holdings Inc., maker of replacement hips and knees, has agreed to buy Abbott Laboratories' spine division for about $360 million in cash. Abbott's spinal business posted $109 million in 2007 sales, representing a tiny fraction of the

Tougher Warnings Ordered on Four Drugs

Federal regulators on Thursday demanded beefed-up warnings on the labels of four big-selling drugs for arthritis and Crohn's disease to alert patients to the risk of serious fungal infections. The Food and Drug Administration ordered stronger warning

Physicists need a little comic relief

MEYRIN, Switzerland — One recent Saturday morning, physicists here shot the first beam of subatomic matter into the most powerful particle accelerator ever built. The machine — a 17-mile circular tunnel that sits 330 feet underground along the

Allied Healthcare Net Declines Due to Manufacturing Delays, Higher Costs

ST. LOUIS, Sept. 4 /PRNewswire-FirstCall/ -- Allied Healthcare Products, Inc. (Nasdaq: AHPI) reported that its net income for the fourth quarter ending June 30 fell about 21 percent, from about $870,000 last year, or 11 cents per share, to about $690,00

Morgan Stanley Resumes Abbott Labs (ABT) at Overweight

Morgan Stanley resumes coverage on Abbott Laboratories (NYSE: ABT) with an Overweight rating. Abbott Laboratories engages in the development, manufacture, and sale of health care products worldwide. Receive full access to all new and archived articles,

Zimmer Holdings to acquire Abbott Spine

WARSAW, Ind. - Orthopedic implant maker Zimmer Holdings Inc. said it is buying a medical device subsidiary of Abbott Laboratories for roughly $360 million in cash. Get stories by e-mail on this topic. Zimmer said it expects to fund the purchase of

Clear

Clear

© 2007- 2008 Newark Morning Ledger Co.  All Rights Reserved.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/